Hologic, Inc. (BMV:HOLX)

Market Cap	305.33B
Revenue (ttm)	76.13B
Net Income (ttm)	10.50B
Shares Out	n/a
EPS (ttm)	45.51
PE Ratio	29.08
Forward PE	16.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14
Average Volume	13
Open	1,260.00
Previous Close	1,263.00
Day's Range	1,260.00 - 1,260.00
52-Week Range	1,260.00 - 1,263.00
Beta	n/a
RSI	n/a
Earnings Date	Nov 3, 2025

About Hologic

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 1985
• Employees: 7,063
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: HOLX

Financial Performance

In 2024, Hologic's revenue was $4.03 billion, a decrease of -0.00% compared to the previous year's $4.03 billion. Earnings were $789.50 million, an increase of 73.14%.

Financial numbers in USD